Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-056117
Filing Date
2025-12-09
Accepted
2025-12-09 16:36:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3507
  Complete submission text file 0001628280-25-056117.txt   5121
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Subject) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-31791 | Film No.: 251559590
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GALECTIN THERAPEUTICS, INC. 4690 PEACHTREE INDUSTRIAL BLVD, STE. 240 NORCROSS GA 30071
Business Address
Shlevin Harold H. (Reporting) CIK: 0001557082 (see all company filings)

Type: 144